It’s not uncommon for some biosecurity colleagues to dismiss the Biological Weapons Convention (BWC) as a regime with an inadequate mandate. Peter Singer and Abdullah Daar, for example, suggest as ...
- Company's first end-to-end center outside of Europe - Accelerates clinical development from molecule to commercial production DARMSTADT, Germany, Sept. 22, 2017 /PRNewswire/ -- Merck, a leading ...
Merck, a leading science and technology company, today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results